Topics
Astrocytoma | Diagnosis | Magnetic resonance imaging
Home > Publications > Topics > Astrocytoma > Diagnosis > Magnetic resonance imaging
Weller
J, de Dios E, Katzendobler S, Corell A, Dénes A,
Schmutzer-Sondergeld M, Javanmardi N, Thon N, Tonn JC, Jakola AS.
The
T1/T2 Ratio is Associated With Resectability in Patients With
Isocitrate Dehydrogenase-Mutant Astrocytomas Central Nervous
System World Health Organization Grades 2 and 3.
Neurosurgery.
2024 Jun 26. doi:
10.1227/neu.0000000000003069. PMID:
38920377. Observational study˰ ˍ
Onishi S, Kojima M, Yamasaki F, Amatya VJ, Yonezawa U, Taguchi A,
Ozono I, Go Y, Takeshima Y, Hiyama E, Horie N.
T2-FLAIR
mismatch sign, an imaging biomarker for CDKN2A-intact in
non-enhancing astrocytoma, IDH-mutant.
Neurosurg
Rev. 2024 Aug 9;47(1):412. doi:
10.1007/s10143-024-02632-5. PMID:
39117984. Observational study. ˍ
Lee MD, Jain R, Galbraith K, Chen A, Lieberman E, Patel SH,
Placantonakis DG, Zagzag D, Barbaro M, Guillermo Prieto Eibl MDP,
Golfinos JG, Orringer DA, Snuderl M.
T2-FLAIR
Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B
Status in IDH-Mutant Astrocytomas.
Clin
Cancer Res. 2024 Aug 15;30(16):3512-3519. doi:
10.1158/1078-0432.CCR-24-0311. PMID:
38829583. Observational study˰
ˍ
Progression/Necrosis
Ozeki Y, Honda-Kitahara M, Yanagisawa S, Takahashi M, Ohno M,
Miyakita Y, Kikuchi M, Nakano T, Hosoya T, Sugino H, Satomi K,
Yoshida A, Igaki H, Kubo Y, Ichimura K, Suzuki H, Masutomi K,
Kondo A, Narita Y.
Early progressive
disease within 2 years in isocitrate dehydrogenase (IDH)-mutant
astrocytoma may indicate radiation necrosis.
Jpn
J Clin Oncol. 2024 Dec 11:hyae151. doi:
10.1093/jjco/hyae151. PMID:
39660448. Observational study˰
ˍ
Differentiation of Glioblastomas and Astrocytomas
Gry
HS, Falk Delgado A.
Differentiation of
Molecular Glioblastomas and Lower-grade Diffuse Astrocytomas Using
MRI Perfusion and Diffusion Parameters.
Clin
Neuroradiol. 2025 Aug 20. doi:
10.1007/s00062-025-01550-3. PMID:
40833458. Observational study˰
ˍ